Literature DB >> 25938949

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.

Russell K Pachynski1, Alexander Scholz2, Justin Monnier3, Eugene C Butcher2, Brian A Zabel4.   

Abstract

Specialized immune cells that infiltrate the tumor microenvironment regulate the growth and survival of neoplasia.  Malignant cells must elude or subvert anti-tumor immune responses in order to survive and flourish. Tumors take advantage of a number of different mechanisms of immune "escape," including the recruitment of tolerogenic DC, immunosuppressive regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSC) that inhibit cytotoxic anti-tumor responses. Conversely, anti-tumor effector immune cells can slow the growth and expansion of malignancies: immunostimulatory dendritic cells, natural killer cells which harbor innate anti-tumor immunity, and cytotoxic T cells all can participate in tumor suppression. The balance between pro- and anti-tumor leukocytes ultimately determines the behavior and fate of transformed cells; a multitude of human clinical studies have borne this out. Thus, detailed analysis of leukocyte subsets within the tumor microenvironment has become increasingly important. Here, we describe a method for analyzing infiltrating leukocyte subsets present in the tumor microenvironment in a mouse tumor model. Mouse B16 melanoma tumor cells were inoculated subcutaneously in C57BL/6 mice. At a specified time, tumors and surrounding skin were resected en bloc and processed into single cell suspensions, which were then stained for multi-color flow cytometry. Using a variety of leukocyte subset markers, we were able to compare the relative percentages of infiltrating leukocyte subsets between control and chemerin-expressing tumors. Investigators may use such a tool to study the immune presence in the tumor microenvironment and when combined with traditional caliper size measurements of tumor growth, will potentially allow them to elucidate the impact of changes in immune composition on tumor growth. Such a technique can be applied to any tumor model in which the tumor and its microenvironment can be resected and processed.

Entities:  

Mesh:

Year:  2015        PMID: 25938949      PMCID: PMC4541547          DOI: 10.3791/52657

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

1.  Changes in fluorescence intensity of selected leukocyte surface markers following fixation.

Authors:  Judith C Stewart; Michelle L Villasmil; Mark W Frampton
Journal:  Cytometry A       Date:  2007-06       Impact factor: 4.355

2.  Transgenic nude mice ubiquitously expressing fluorescent proteins for color-coded imaging of the tumor microenvironment.

Authors:  Robert M Hoffman
Journal:  Methods Mol Biol       Date:  2014

Review 3.  Imaging in cancer immunology:phenotyping immune cell subsets in situ in FFPE tissue sections.

Authors:  James R Mansfield
Journal:  MLO Med Lab Obs       Date:  2014-06

4.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Authors:  Michael A Curran; Welby Montalvo; Hideo Yagita; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease.

Authors:  Husein Hadeiba; Tohru Sato; Aida Habtezion; Cecilia Oderup; Junliang Pan; Eugene C Butcher
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.

Authors:  Russell K Pachynski; Brian A Zabel; Holbrook E Kohrt; Nicole M Tejeda; Justin Monnier; Christina D Swanson; Alison K Holzer; Andrew J Gentles; Gizette V Sperinde; Abdolhossein Edalati; Husein A Hadeiba; Ash A Alizadeh; Eugene C Butcher
Journal:  J Exp Med       Date:  2012-07-02       Impact factor: 14.307

9.  Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer.

Authors:  Andrea Schietinger; Ainhoa Arina; Rebecca B Liu; Sam Wells; Jianhua Huang; Boris Engels; Vytas Bindokas; Todd Bartkowiak; David Lee; Andreas Herrmann; David W Piston; Mikael J Pittet; P Charles Lin; Tomasz Zal; Hans Schreiber
Journal:  Oncoimmunology       Date:  2013-11-04       Impact factor: 8.110

10.  Heterogeneity of respiratory dendritic cell subsets and lymphocyte populations in inbred mouse strains.

Authors:  Holger Hackstein; Andreas Wachtendorf; Sabine Kranz; Jürgen Lohmeyer; Gregor Bein; Nelli Baal
Journal:  Respir Res       Date:  2012-10-15
View more
  11 in total

1.  A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects.

Authors:  Wei-Yun Lai; Bo-Tsang Huang; Jen-Wei Wang; Pei-Ying Lin; Pan-Chyr Yang
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-13

2.  Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors.

Authors:  Jared M Newton; Aurelie Hanoteau; Andrew G Sikora
Journal:  J Vis Exp       Date:  2018-06-07       Impact factor: 1.355

3.  A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect.

Authors:  Bo-Tsang Huang; Wei-Yun Lai; Yi-Chung Chang; Jen-Wei Wang; Shauh-Der Yeh; Emily Pei-Ying Lin; Pan-Chyr Yang
Journal:  Mol Ther Nucleic Acids       Date:  2017-08-15       Impact factor: 8.886

4.  Circadian disruption promotes tumor growth by anabolic host metabolism; experimental evidence in a rat model.

Authors:  Natalí N Guerrero-Vargas; Raful Navarro-Espíndola; Mara A Guzmán-Ruíz; María Del Carmen Basualdo; Estefania Espitia-Bautista; Ana López-Bago; Ricardo Lascurain; Cinthya Córdoba-Manilla; Ruud M Buijs; Carolina Escobar
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

5.  In Vitro and In Vivo Tumor Growth Inhibition by Glutathione Disulfide Liposomes.

Authors:  Satya S Sadhu; Shenggang Wang; Rakesh Dachineni; Ranjith Kumar Averineni; Yang Yang; Huihui Yin; G Jayarama Bhat; Xiangming Guan
Journal:  Cancer Growth Metastasis       Date:  2017-03-10

6.  Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model.

Authors:  Mary-Ann N Jallad; Abdo R Jurjus; Elias A Rahal; Alexander M Abdelnoor
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

7.  Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.

Authors:  Gabriela M Wiedemann; Celina Aithal; Angelina Kraechan; Constanze Heise; Bruno L Cadilha; Jin Zhang; Peter Duewell; Robert Ballotti; Stefan Endres; Corine Bertolotto; Sebastian Kobold
Journal:  Transl Oncol       Date:  2018-11-28       Impact factor: 4.243

8.  Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.

Authors:  Seung Hyeon Kim; Soma Saeidi; Xiancai Zhong; Shin-Young Gwak; Ishrat Aklima Muna; Sin-Aye Park; Seong Hoon Kim; Hye-Kyung Na; Yeonsoo Joe; Hun Taeg Chung; Kyoung-Eun Kim; Wonshik Han; Young-Joon Surh
Journal:  Neoplasia       Date:  2020-10-08       Impact factor: 5.715

9.  Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment.

Authors:  Alison E Obr; Sushil Kumar; Yun-Juan Chang; Joseph J Bulatowicz; Betsy J Barnes; Raymond B Birge; Deborah A Lazzarino; Emily Gallagher; Derek LeRoith; Teresa L Wood
Journal:  Breast Cancer Res       Date:  2018-11-20       Impact factor: 6.466

10.  Cnp Promoter-Driven Sustained ERK1/2 Activation Increases B-Cell Activation and Suppresses Experimental Autoimmune Encephalomyelitis.

Authors:  Marisa A Jeffries; Alison E Obr; Kelly Urbanek; Sharyl L Fyffe-Maricich; Teresa L Wood
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.